recommended for detection of plasma kallikrein of human origin by WB, IP and ELISA
Modification Notes
Plasma prekallikrein is a glycoprotein that is synthesized in the liver and is secreted into the blood as a single polypeptide chain that participates in the surface-dependent activation of blood coagulation, fibrinolysis, kinin generation and inflammation. The human plasma prekallikrein gene maps to chromosome 4q34-q35 and encodes a serine proteinase known as Fletcher factor. Plasma prekallikrein converts to plasma kallikrein by Factor XII A through the cleavage of an internal Arg-Ile bond. Plasma kallikrein releases bradykinin when activated by Gram-negative septicemia or irreversible hemorrhagic shock. Plasma prekallikrein activation induces the cleavage of high molecular weight kininogen (HK) and subsequent liberation of bradykinin. Cleaved HK is antiangiogenic, and bradykinin stimulates tPA liberation and nitric oxide formation. Activated plasma kallikrein promotes single-chain urokinase activation and subsequent plasminogen activation. Kininigens and their breakdown products are antithrombin agents .
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPELISA
WB:1:500~1:2000 IP:1:100~1:500 Notes:Optimal dilutions/concentrations should be determined by the researcher.
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
recommended for detection of plasma kallikrein of human origin by WB IP and ELISA
Tissue Specificity
recommended for detection of plasma kallikrein of human origin by WB, IP and ELISA